N-Acetyl-aspartate (NAA) is almost exclusively localized in neurons in the mature brain and might be used as a neuronal marker. It has been reported that the NAA content in human brain is decreased in neurodegenerative diseases and in stroke. Since the NAA content can be determined by nuclear magnetic resonance techniques, it has potential as a diagnostic and prognostic marker. The objective of this study was to examine the change of NAA content and related substances following cerebral ischemia and compare the results to the damage of the tissue. We used rats to study the changes of NAA, N-acetyl-aspartyl-glutamate (NAAG), glutamate, and aspartate contents over a time course of 24 h in brain regions affected by either permanent middle cerebral artery occlusion (focal ischemia) or decapitation (global ischemia). The decreases of NAA and NAAG contents following global brain ischemia were linear over time but significant only after 4 and 2 h, respectively. After 24 h, the levels of NAA and NAAG were 24 and 44% of control values, respectively. The concentration of glutamate did not change, whereas the aspartate content increased at a rate comparable with the rate of decrease of NAA content. This is consistent with NAA being preferentially degraded by the enzyme amidohydrolase II in global ischemia. In focal ischemia, there was a rapid decline of NAA within the first 8 h of ischemia followed by a slower rate of reduction. The reductions of NAA and NAAG contents in focal ischemia were significant after 4 and 24 h, respectively. After 24 h, the NAA and NAAG contents were 33 and 64% of control values, respectively. Also, the glutamate and aspartate contents exhibited significant decreases in focal ischemic tissue. Our studies show that NAA decreases during brain ischemia, the initial rate being faster in focal ischemia than in global ischemia. In rat transient focal ischemia, others have shown that a middle cerebral artery occlusion of 2- to 3-h duration is sufficient to produce an infarct that is similar in size to that following permanent occlusion for 24 h. The fact that we observed only a 10% decrease of NAA content 2 h after occlusion demonstrates that the NAA content of the tissue does not reflect neuronal viability. Thus, the incompetence with which ischemic/infarcted tissue removes NAA will lead to overestimation of the number of viable neurons in acute situations. Only when steady state prevails may [NAA] be used as a marker of viable nerve cells.
BerlinguetLLalibertéM, (1966) Metabolism of N-acetylaspartic acid in mice. Can J Biochem44:783–789
2.
BetzALKeepRFBeerMERenX-D, (1994) Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab14:29–37
3.
BirkenDLOldendorfWH, (1989) N-Acetyl-l-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev13:23–31
4.
BruhnHFrahmJGyngellMLMerboldtKDHänickeWSauterR, (1989) Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy. Magn Res Med9:126–131
5.
BrunsFHReinauerHStorkW, (1967) Analytische und biologische Studien über den Gehalt an N-acetyl-l-aspartate im Gehirn. Hoppe Seylers Z Physiol Chem348:512–518
6.
BurriRBiglerPStraehlPPosseSColomboJ-PHerschkowitzN, (1990) Brain development: 1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods. Neurochem Res15:1009–1016
7.
BurriRSteffenCHerschkowitzN, (1991) N-Acetyl-l-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev Neurosci13:403–411
8.
D'ArcangeloPBrancatiA, (1990) Distribution of N-acetylaspartate, N-acetylaspartylglutamate, free glutamate and aspartate following complete mesencephalic transection in the rat neuraxis. Neurosci Lett114:82–88
9.
D'ArcangeloPBrancatiACecchiL, (1968) Sulla stabilitá degli acidi N-acetilaspartico e N-acetilaspartil-glutammico in campioni di cerello. Boll Soc Ital Biol Sper45:267–270
10.
DickinsonLDBetzAL, (1992) Attenuated development of ischemic brain edema in vasopressin-deficient rats. J Cereb Blood Flow Metab12:681–690
11.
DunlopDSMcHaleDMLajthaA, (1992) Decreased brain N-acetylaspartate in Huntington's disease. Brain Res580:44–48
GideonPHenriksenOSperlingBChristiansenPOlsenTSJørgensenHSArlien-SøborgP, (1992) Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. Stroke23:1566–1572
14.
GoldsteinFB, (1959) Biosynthesis of N-acetyl-l-aspartic acid. J Biol Chem234:2702–2706
15.
GoldsteinFB, (1976) Amidohydrolases of brain; enzymatic hydrolysis of N-acetyl-l-aspartate and other N-acyl-l-amino acids. J Neurochem26:45–49
16.
GrahamGDBlamireAMHowsemanAMRothmanDLFayadPBBrassLMPetroffOACShulmanRGPrichardJW, (1992) Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke23:333–340
17.
GrahamGDBlamireAMRothmanDLBrassLMFayadPBPetroffOACPrichardJW, (1993) Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke24:1891–1896
18.
HagbergHLehmannASandbergMNyströmBJacobsonIHambergerA, (1985) Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab5:413–419
19.
HidaKKweeILNakadaT, (1992) In vivo 1H and 31P NMR spectroscopy of the developing rat brain. Magn Res Med23:31–36
20.
HuggJWDuijnJHMatsonGBMaudsleyAATsurudaJSGelinasDFWeinerMW, (1992) Elevated lactate and alkalosis in chronic human brain infarction observed by 1H and 31P MR spectroscopic imaging. J Cereb Blood Flow Metab12:734–744
21.
JacobsonKB, (1959) Studies on the role of N-acetylaspartic acid in mammalian brain. J Gen Physiol43:323–333
22.
KaplanBBrintSTanabeJJacewitzMWangX-JPulsinelliW, (1991) Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke22:1032–1039
23.
KollerKJZaczekRCoyleJT, (1984) N-Acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem43:1136–1142
24.
KvittingenEAGuldalGBørstingSSkalpeIOStokkeOJellumE, (1986) N-Acetylaspartic aciduria in a child with a progressive cerebral atrophy. Clin Chim Acta158:217–227
25.
LamplYPaniriYEshelYSarova-PinhasI, (1990) Cerebrospinal fluid lactate dehydrogenase levels in early stroke and transient ischemic attacks. Stroke21:854–857
26.
MatsumotoKGrafRRosnerGTaguchiJHeissW-D, (1993) Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab13:586–594
27.
MemezawaHSmithM-LSiesjöBK, (1992) Penumbral tissue salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke23:552–559
28.
MeyerhoffDJMacKaySBachmanLPooleNDillonWPFeinG Weiner (1993) Reduced N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: In vivo 1H magnetic resonance spectroscopic imaging. Neurology43:509–515
29.
MonseinLHMathewsVPBarkerPBPardoCABlackbandSJWhitlowWDWomgDFBryanRN, (1993) Irreversible regional cerebral ischemia: Serial MR imaging and proton MR spectroscopy in a nonhuman primate model. AJNR14:963–970
30.
NadlerJVCooperJR, (1972) N-Acetyl-l-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem19:313–319
31.
PerryTLHansenSGandhamSS, (1981) Postmortem changes of amino compounds in human and rat brain. J Neurochem36:406–412
32.
PetroffOACGrahamGDBlamireAMAl-RayessMRothmanDLFayadPBBrassLMShulmanRGPrichardJW, (1992) Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes. Neurology42:1349–1354
33.
PhillisJWWalterGA, (1989) Hypoxia/hypotension evoked release of glutamate and aspartate from the rat cerebral cortex. Neurosci Lett106:147–151
34.
PlaitakisAConstantakakisE, (1993) Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis. Brain Res Bull30:381–386
35.
RobinsonMBBlakelyRDCuotoRCoyleJT, (1985) Hydrolysis of the brain dipeptide N-acetyl-l-aspartyl-l-glutamate. Identification and characterization of a novel N-acetylated-a-linked acidic dipeptidase activity from rat brain. J Biol Chem262:14498–14506
36.
RothsteinJDTsaiGKunclRWClawsonLCornblathDRDrachmanDBPestronkAStauchBLCoyleJT, (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol28:18–25
37.
ShimadaNGrafRRosnerGHeissW-D, (1993) Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J Neurochem60:66–71
38.
StrandTMarklundSL, (1992) Release of superoxide dismutase into cerebrospinal fluid as a marker of brain lesion in acute cerebral infarction. Stroke23:515–518
39.
TallanHH, (1957) Studies on the distribution of N-acetyl-l-aspartic acid in brain. J Biol Chem224:257–264
40.
TallanHHMooreSSteinWH, (1956) N-Acetyl-l-aspartic acid in brain. J Biol Chem219:257–264
41.
TamuraAGrahamDIMcCullochJTeasdaleGM, (1981) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab1:53–60
42.
TsaiGCorkLCSlusherBSPriceDCoyleJT, (1993) Abnormal acidic amino acids and N-acetylaspartylglutamate in hereditary canine motoneuron disease. Brain Res629:305–309
43.
UrenjakJWilliamsSRGadianDGNobleM, (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem59:55–61
44.
UrenjakJWilliamsSRGadianDGNobleM, (1993) Proton magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci13:981–989
45.
WilliamsVGrossmanRGEdmundsSM, (1980) Volume and surface area estimates of astrocytes in the sensorimotor cortex of the rat. Neuroscience5:1919–1923
46.
WoilerCTD'AdamoAF, (1971) Brain N-acetyl-l-aspartate hydrolase: Inhibition by aspartate and possible regulatory role to aspartate as transmitter. Pharmacologist13:283